Literature DB >> 18770035

Palliation of malignant obstructive jaundice.

G Garcea1, S L Ong, A R Dennison, D P Berry, G J Maddern.   

Abstract

Peri-ampullary and hepatic malignancies will frequently present with obstructive jaundice. For unresectable tumors, effective and lasting decompression of the biliary tree is essential to improve quality of life and survival. An overview of present treatment modalities for palliation of obstructive jaundice is provided, including a systematic review of the English literature regarding the optimum choice of palliation.

Entities:  

Mesh：

Year:  2008        PMID： 18770035     DOI： 10.1007/s10620-008-0479-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  113 in total

1.  Duodenal perforation by a biliary endoprosthesis: evaluation by hepatobiliary scintigraphy.

Authors:  D Schuster; D M Achong; T A Knox; K A Fawaz
Journal:  J Clin Gastroenterol       Date:  1992-09       Impact factor: 3.062

2.  Percutaneous transhepatic biliary drainage: experience with 311 procedures.

Authors:  R W Günther; H Schild; M Thelen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

3.  Metallic biliary endoprosthesis causing duodenal perforation and acute upper gastrointestinal bleeding.

Authors:  B J Marano; C A Bonanno
Journal:  Gastrointest Endosc       Date:  1994 Mar-Apr       Impact factor: 9.427

4.  Relief of malignant obstructive jaundice by percutaneous insertion of a permanent prosthesis in the biliary tree.

Authors:  R V Pereiras; O J Rheingold; D Huston; J Mejia; M Viamonte; R O Chiprut; E R Schiff
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

5.  Choledochoduodenostomy for palliation in unresectable pancreatic cancer.

Authors:  L A DiFronzo; S Egrari; T X O'Connell
Journal:  Arch Surg       Date:  1998-08

Review 6.  Medical palliation of the jaundiced patient with pruritus.

Authors:  Nora V Bergasa
Journal:  Gastroenterol Clin North Am       Date:  2006-03       Impact factor: 3.806

7.  Complications after ERCP in patients with primary sclerosing cholangitis.

Authors:  Jason P Etzel; Sue C Eng; Cynthia W Ko; Scott D Lee; Michael D Saunders; Bruce Y Tung; Michael B Kimmey; Kris V Kowdley
Journal:  Gastrointest Endosc       Date:  2007-12-03       Impact factor: 9.427

8.  Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.

Authors:  Hiroshi Ishii; Junji Furuse; Michitaka Nagase; Mitsuhiko Kawashima; Hiroshi Ikeda; Masahiro Yoshino
Journal:  Hepatogastroenterology       Date:  2004 Jul-Aug

9.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

10.  A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction.

Authors:  A A Polydorou; E M Chisholm; A A Romanos; J F Dowsett; P B Cotton; A R Hatfield; R C Russell
Journal:  Endoscopy       Date:  1989-11       Impact factor: 10.093
View more
  5 in total

Review 1.  Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.

Authors:  Shuangxi Li; Xuewen He; Lei Dang; Fangyu Xu; Jin Fang; Fenqiang Li; Wenhui Wang
Journal:  Dig Dis Sci       Date:  2018-01-05       Impact factor: 3.199

2.  Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days?

Authors:  John M Lyons; Ami Karkar; Camilo C Correa-Gallego; Michael I D'Angelica; Ronald P DeMatteo; Yuman Fong; T Peter Kingham; William R Jarnagin; Murray F Brennan; Peter J Allen
Journal:  HPB (Oxford)       Date:  2012-05-15       Impact factor: 3.647

3.  Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study.

Authors:  Tianxiao Wang; Jiahong Dong; Yuewei Zhang; Zhizhong Ren; Ying Liu; Xiaowei Yang; Dawei Sun; Yaqin Wang
Journal:  Ann Transl Med       Date:  2022-04

4.  A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer.

Authors:  Caroline Williamsson; Johanna Wennerblom; Bobby Tingstedt; Claes Jönsson
Journal:  HPB (Oxford)       Date:  2015-12-08       Impact factor: 3.647

5.  Biliary stenting in advanced malignancy: an analysis of predictive factors for survival.

Authors:  Mehran Afshar; Koudeza Khanom; Yuk Ting Ma; Pankaj Punia
Journal:  Cancer Manag Res       Date:  2014-12-10       Impact factor: 3.989
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.